Septal injection in comparison with inferior turbinates injection of botulinum toxin A in patients with allergic rhinitis

Journal of Research in Medical Sciences

Volumn 18, Issue 5, 2013, Pages 400-404

  Abtahi, Sayed Mojtaba ^a   Hashemi, Sayed Mostafa ^a   Abtahi, Sayed Hamidreza ^a   Bastani, Bagher ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allergic rhinitis; Botulinum toxin a; Quality of life

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONJUNCTIVITIS; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FEMALE; FOLLOW UP; HUMAN; MALE; MUCOSAL DRYNESS; NASAL PRURITUS; NOSE OBSTRUCTION; NOSE SEPTUM; QUALITY OF LIFE; QUESTIONNAIRE; RHINORRHEA; SEPTAL DRUG ADMINISTRATION; SNEEZING; TURBINATE DRUG ADMINISTRATION;

EID: 84879891474     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician 2010;81:1440-6.
2. Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H, et al. Japanese guideline for allergic rhinitis. Allergol Int 2011;60:171-89.
3. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000;6:373-8.
4. Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol 2011;29:297-306.
5. Derebery J, Meltzer E, Nathan RA, Stang PE, Campbell UB, Corrao M, et al. Rhinitis symptoms and comorbidities in the United States: Burden of rhinitis in America survey. Otolaryngol Head Neck Surg 2008;139:198-205.
6. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-64.
7. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-334.
8. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-8.
9. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000;162:1391-6.
10. Tripathi A, Patterson R. Impact of allergic rhinitis treatment on quality of life. Pharmacoeconomics 2001;19:891-9.
11. Rohrbach S, Junghans K, Köhler S, Laskawi R. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. Head Face Med 2009;5:18.
12. Price D, Bond C, Bouchard J, Costa R, Keenan J, Levy ML, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis. Prim Care Respir J 2006;15:58-70.
13. Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008;38:260-75.
14. Palomar FJ, Mir P. Neurophysiological changes after intramuscular injection of botulinum toxin. Clin Neurophysiol 2012;123:54-60.
15. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.
16. Kim KS, Kim SS, Yoon JH, Han JW. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998;112:248-51.
17. Ozcan C, Vayisoglu Y, Doǧu O, Görür K. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol 2006;27:314-8.
18. Sapci T, Yazici S, Evcimik MF, Bozkurt Z, Karavus A, Ugurlu B, et al. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Rhinology 2008;46:45-51.
19. van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy 2005;60:1471-81.
20. Yang TY, Jung YG, Kim YH, Jang TY. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. Otolaryngol Head Neck Surg 2008;139:367-71.
21. Unal M, Sevim S, Doǧu O, Vayisoǧlu Y, Kanik A. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: A double-blind, placebo-controlled clinical trial. Acta Otolaryngol 2003;123:1060-3.
22. Braun T, Gürkov R, Kramer MF, Krause E. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: A pilot study. Am J Otolaryngol 2012;33:64-7.
23. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76.
24. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen). Allergy 2008;63:8-160.
25. Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S, et al. Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003;58:289-94.
26. Hansel F. Clinical and histopathologic studies of the nose and sinuses in allergy. J Allergy 1929;1:43-70.
27. Wen WD, Yuan F, Hou YP, Song YF. Experimental studies for botulinum toxin type A on allergic rhinitis in the rat. Zhonghua Er Bi Yan Hou Ke Za Zhi 2004;39:97-101.
28. Laskawi R. The use of botulinum toxin in head and face medicine: An interdisciplinary field. Head Face Med 2008;4:5.
29. Augusto AG, Bussolotti Filho I, Dolci JE, König Júnior B. Structural and ultrastructural study of the anterior portion of the nasal septum and inferior nasal concha. Ear Nose Throat J 2001;80:325-7, 333-8.
30. Rohrbach S, Olthoff A, Laskawi R, Giefer B, Götz W. Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol 2001;110:1045-50.
31. Hadar T, Ophir D, Yaniv E, Berger G. Inferior turbinate arterial supply: Histologic analysis and clinical implications. J Otolaryngol 2005;34:46-50.